应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06160 百济神州
交易中 05-08 13:07:05
191.200
+2.300
+1.22%
最高
194.300
最低
189.600
成交量
387.44万
今开
189.900
昨收
188.900
日振幅
2.49%
总市值
2,946亿
流通市值
2,727亿
总股本
15.41亿
成交额
7.41亿
换手率
0.27%
流通股本
14.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中金:维持百济神州(06160)跑赢行业评级 目标价250港元
智通财经 · 09:37
中金:维持百济神州(06160)跑赢行业评级 目标价250港元
【券商聚焦】中国银河:医药行业进入复苏周期 CXO板块景气度较高
金吾财讯 · 09:00
【券商聚焦】中国银河:医药行业进入复苏周期 CXO板块景气度较高
多家药企高管生变:恒瑞、复星、阿斯利康、辉瑞…
赛柏蓝 · 05-07 19:53
多家药企高管生变:恒瑞、复星、阿斯利康、辉瑞…
百济神州:5月6日召开业绩说明会,AJ Asset Management、Everbright PGIM Fund等多家机构参与
证券之星 · 05-07 19:30
百济神州:5月6日召开业绩说明会,AJ Asset Management、Everbright PGIM Fund等多家机构参与
异动解读 | 百济神州盘中大涨5.11%,一季度业绩扭亏为盈并上调全年指引
异动解读 · 05-07 09:36
异动解读 | 百济神州盘中大涨5.11%,一季度业绩扭亏为盈并上调全年指引
港股异动 | 百济神州(06160)绩后高开逾4% 一季度净利同比增长178.02倍 百悦泽全球销售额11亿美元
智通财经 · 05-07 09:25
港股异动 | 百济神州(06160)绩后高开逾4% 一季度净利同比增长178.02倍 百悦泽全球销售额11亿美元
港股开盘强势 恒指高开1.21% 快手-W(01024)涨5.20%
金吾财讯 · 05-07 09:24
港股开盘强势 恒指高开1.21% 快手-W(01024)涨5.20%
智通港股早知道 | 碳酸锂现货价格大幅上行 百济神州(06160)一季度净利润同比增长178.02倍
智通财经 · 05-07 07:09
智通港股早知道 | 碳酸锂现货价格大幅上行 百济神州(06160)一季度净利润同比增长178.02倍
核心产品放量!百济神州一季度营收达105亿元
21世纪经济报道 · 05-06 21:26
核心产品放量!百济神州一季度营收达105亿元
百济神州(688235.SH):2026年第一季度归母净利润16.08亿元
智通财经网 · 05-06 19:37
百济神州(688235.SH):2026年第一季度归母净利润16.08亿元
百济神州更新4月股份变动月报表,股本维持稳定
公告速递 · 05-06 19:26
百济神州更新4月股份变动月报表,股本维持稳定
百济神州2026年第一季度营收15.13亿美元,经调整净利润3.75亿美元
公告速递 · 05-06 18:47
百济神州2026年第一季度营收15.13亿美元,经调整净利润3.75亿美元
百济神州Q1净利润16.08亿元,同比扭亏为盈
老虎资讯综合 · 05-06 18:34
百济神州Q1净利润16.08亿元,同比扭亏为盈
百济神州最新公告:预计2026年营业收入436亿元-452亿元
证券之星 · 05-06 18:29
百济神州最新公告:预计2026年营业收入436亿元-452亿元
百济神州首次全年盈利背后:累计亏损超600亿元,大单品依赖与地缘政治隐忧|财报异动透视镜
华夏时报网 · 05-01
百济神州首次全年盈利背后:累计亏损超600亿元,大单品依赖与地缘政治隐忧|财报异动透视镜
财报前瞻|百济神州盈利质量与BD进展成看点,盘后发布业绩
财报Agent · 04-29
财报前瞻|百济神州盈利质量与BD进展成看点,盘后发布业绩
盈利不足两月,百济神州豪掷20亿美元押注三抗
21世纪经济报道 · 04-28
盈利不足两月,百济神州豪掷20亿美元押注三抗
百济神州(06160)与华辉安健签订《合作协议》引进三特异性创新药全球独家开发权益
智通财经 · 04-27
百济神州(06160)与华辉安健签订《合作协议》引进三特异性创新药全球独家开发权益
每周股票复盘:百济神州(688235)将发布2026年一季报
证券之星 · 04-26
每周股票复盘:百济神州(688235)将发布2026年一季报
百济神州:公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定
证券日报 · 04-20
百济神州:公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定
暂无数据
公司概况
公司名称:
百济神州
所属市场:
SEHK
上市日期:
--
主营业务:
BeOne Medicines AG(原名:BeiGene Ltd)是一家全球肿瘤学公司,致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤,致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4(IgG4)抗程序性细胞死亡蛋白1(PD-1)单克隆抗体,具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ(Fcy)受体的结合,帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。
发行价格:
--
{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":191.2,"timestamp":1778216810233,"preClose":188.9,"halted":0,"volume":3874434,"delay":0,"changeRate":0.012175754367390063,"floatShares":1426000000,"shares":1541000000,"eps":1.4872565595841942,"marketStatus":"交易中","change":2.3,"latestTime":"05-08 13:07:05","open":189.9,"high":194.3,"low":189.6,"amount":740589979,"amplitude":0.024881,"askPrice":191.2,"askSize":13300,"bidPrice":191.1,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":2.6518410670674433,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778227800000},"marketStatusCode":2,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":188.9,"openAndCloseTimeList":[[1778203800000,1778212800000],[1778216400000,1778227200000]],"volumeRatio":2.496403,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":248.78,"timestamp":1778216820000,"preClose":254.4,"halted":0,"volume":2900700,"delay":0,"premium":"-33.21"},"impliedVol":0.4315,"impliedVolPercentile":0.8219},"requestUrl":"/m/hq/s/06160/tweets","defaultTab":"tweets","newsList":[{"id":"2633107844","title":"中金:维持百济神州(06160)跑赢行业评级 目标价250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633107844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633107844?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:37","pubTimestamp":1778204248,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研报称,综合考虑百济神州费用控制,维持2026年收入预测不变,上调盈利预测7.1%至6.5亿美元,并维持2027年盈利预测不变。该行维持跑赢行业评级,基于DCF模型,该行维持A/H/US股目标价320元/250港币/420美元。1Q26替雷利珠单抗全球销售额2.06亿美元,YoY +20%。GAAP净利润达到2.27亿美元,单季度盈利首次超过2亿美元,超过该行预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688235","06160","ONC","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633687104","title":"【券商聚焦】中国银河:医药行业进入复苏周期 CXO板块景气度较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2633687104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633687104?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:00","pubTimestamp":1778202049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券表示,2025年医药行业上市公司营业收入增长0.4%,归母净利润增长3.9%,扣非净利润下降4.1%,2026年一季度营业收入增长1.1%,归母净利润下降3.2%,扣非净利润增长2.0%。2025全年医药行业收入端小幅微增,主要系医保控费趋严,仿制药、耗材等集采常态化开展导致行业承压。2026年一季度创新药产业链高景气度延续,收入增幅扩大、非经常性损益占比下降,行业整体经营盈利能力提升,进入复苏上行周期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU1794554557.SGD","01530","LU1969619763.USD","CXO","LU0561508036.HKD","LU0348735423.USD","02196","02228","LU2476274720.SGD","BK1207","LU2488822045.USD","LU0348783233.USD","BK1593","09688","LU0417516571.SGD","LU1719994722.HKD","BK1161","02268","LU0417516738.SGD","LU1303224171.USD","03933","BK1583","06160","06821","09926","LU0588546209.SGD","LU0417516902.SGD","LU1251922891.USD","LU0640798160.USD","HK0000165453.HKD","BK1197","LU0348766576.USD","01789","LU1961090484.USD","BK0276","LU0348767384.USD","BK1141","02367","BK1588","601881","LU2328871848.SGD","LU2778985437.USD","06881","BK1585","LU0307460666.USD","BK0188","LU0634319403.HKD","01099","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家药企高管生变:恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633794147?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日,恒瑞医药发布公告,正式完成新一届董事会和管理层聘任。复星医药4月2日,复星医药发布首席财务官变更公告,因工作安排调整,陈战宇辞去首席财务官职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ONC","AZNH","LU1057294990.SGD","LU0225771236.USD","SG9999001176.SGD","BK4588","LU0456855351.SGD","SG9999003800.SGD","BK4568","IE00BLSP4239.USD","LU0234572021.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4585","LU2456880835.USD","BK4533","LU0321505439.SGD","LU2417539215.USD","IE00BBT3K403.USD","600276","LU2462157665.USD","02196","LU0306807586.USD","LU0321505868.SGD","LU2236285917.USD","LU0122379950.USD","LU2237443978.SGD","SG9999013999.USD","SGXZ57979304.SGD","02142","LU0170899867.USD","SG9999011175.SGD","LU2237443382.USD","LU0058720904.USD","LU0868494617.USD","SG9999001176.USD","LU1066051498.USD","LU2237443549.SGD","LU0109394709.USD","SG9999002224.SGD","IE00B19Z3581.USD","BK4581","BK4534","IE0002270589.USD","06160","LU1883839398.USD","BK4599","01276","BK4592","LU0225284248.USD","LU1829250122.USD","600196","BK4007","LU1894683264.USD","688235","LU2237443895.HKD","PFE","SG9999002232.USD","BK4550","LU2237443622.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU0320765992.SGD","LU2237443465.HKD","AZN","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1894683348.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149675","title":"百济神州:5月6日召开业绩说明会,AJ Asset Management、Everbright PGIM Fund等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633149675?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:30","pubTimestamp":1778153458,"startTime":"0","endTime":"0","summary":"一季度产生了约2,000万美元的非经常性净额,仅发生在一季度,公司预计其影响将贯穿全年。整体业务布局态势良好。公司将于今年SCO年会公布1期临床数据,相关摘要即将发布。在联合替雷利珠单抗 + 贝伐珠单抗一线治疗HCC的临床试验中,目前已入组超 40例患者。于今年1月在中国获批,获批后仅8天便正式商业化上市。年初至今,国内已有超300家医院开始使用该药物开展患者治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700035908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","LU1719994722.HKD","688235","BK1500","BK1588","LU0307460666.USD","BK0239","LU1969619763.USD","LU2328871848.SGD","LU0588546209.SGD","BK1583","LU1251922891.USD","LU1303224171.USD","06160","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124238137","title":"异动解读 | 百济神州盘中大涨5.11%,一季度业绩扭亏为盈并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1124238137","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124238137?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:36","pubTimestamp":1778117775,"startTime":"0","endTime":"0","summary":"百济神州今日盘中大涨5.11%,引起了市场的广泛关注。消息面上,公司发布了2026年第一季度强劲的业绩报告。报告显示,公司营业收入同比增长31%,归母净利润达16.08亿元,同比实现扭亏为盈。核心产品泽布替尼全球销售额持续增长,同时公司还上调了全年收入指引的上限。此外,公司在研管线进展顺利,多项研究获国际学术会议展示,并通过业务拓展丰富了产品管线,进一步增强了投资者对公司未来增长潜力的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633416218","title":"港股异动 | 百济神州(06160)绩后高开逾4% 一季度净利同比增长178.02倍 百悦泽全球销售额11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633416218","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633416218?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:25","pubTimestamp":1778117150,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百济神州绩后高开逾4%,截至发稿,涨4.07%,报189.4港元,成交额4130.72万港元。消息面上,5月6日,百济神州公布2026年第一季度业绩,全球总收入达约15.13亿美元,同比增长35%。经调整经营利润约4.14亿美元,同比增长197%;经调整净利润约3.75亿美元,同比增长175%;净利润约2.27亿美元,同比增长178.02倍;自由现金流约1.61亿美元,同比增长14.03倍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1161","BK4139","688235","LU1303224171.USD","BK4585","LU2328871848.SGD","BK1583","BK4526","LU1770034418.SGD","LU0307460666.USD","LU1719994722.HKD","LU1969619763.USD","BK4588","06160","BK1588","LU1251922891.USD","LU0588546209.SGD","BK1500","ONC","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633162625","title":"港股开盘强势 恒指高开1.21% 快手-W(01024)涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633162625","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633162625?lang=zh_cn&edition=full","pubTime":"2026-05-07 09:24","pubTimestamp":1778117045,"startTime":"0","endTime":"0","summary":"金吾财讯 | 美伊将达成结束战争协议,刺激大市气氛向上,隔晚美股强势带动港股情绪,恒指高开1.21%,国企指数高开1.3%,恒生科技指数高开2.41%。期内,经调整净利润3.75亿美元,按年增加175%。东方证券高开1.87%,公司宣布,向卖方收购上海证券合计100%股权。该公司已向上海证交所申请A股5月7日复牌。内地股市假后复市,大市走势向好,沪综指高开高走,收市上升1.2%,沪深两市成交额超过三万亿元水平。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980764","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09961","LU1115378108.SGD","LU0348783233.USD","LU0611395673.USD","LU1808992512.USD","BK1095","513600","LU0307460666.USD","LU1303224171.USD","LU1634259557.SGD","LU0972618739.USD","BK1610","BK1521","LU2097828714.EUR","LU0890818403.SGD","LU1023057109.AUD","ONC","SG9999006597.SGD","LU0348805143.USD","01088","LU0417516902.SGD","LU0708995583.HKD","HSTECH","LU2097828631.EUR","LU0348735423.USD","LU1720050803.USD","SG9999001093.SGD","BK1528","CJEWY","LU0348827113.USD","LU0348783662.USD","SGXZ62798434.SGD","BK1615","06160","BK1608","BK4588","LU0293314216.USD","LU1497734951.SGD","SG9999003461.SGD","02833","LU0405327494.USD","IE00B19Z5X02.USD","601857","LU0405327148.USD","LU0320764599.SGD","LU0441854154.USD","LU1794554557.SGD","600938","BABA","LU1770034418.SGD","LU2293587155.HKD","LU0348766576.USD","LU0181495838.USD","LU0675040207.SGD","LU0572944931.SGD","LU2097828805.USD","LU2097828557.USD","LU1251922891.USD","LU0314109678.HKD","LU0456827905.SGD","LU0359201612.USD","LU0359202008.SGD","LU1831875114.USD","LU1224444064.USD","HHImain","LU0287142896.SGD","XYIGY","00300","IE00BQJZWZ67.USD","LU1497733557.USD","LU2097828474.EUR","LU1188198961.HKD","09888","LU1497733631.SGD","LU1522347837.USD","BIDU","LU0634319403.HKD","LU0210526637.USD","LU0211977185.USD","01378","LU0593848301.USD","00883","LU2399975544.HKD","03958","BK1226","HSI","LU2039709279.SGD","00868","LU0052750758.USD","688235","SGXZ86797644.SGD","03993","SG9999014674.SGD","00857","01024","BK1591","LU0244354667.USD","LU0640798160.USD","LU2328871848.SGD","LU1634259391.SGD","LU0417516571.SGD","BK4585","LU0173614495.USD","LU0140636845.USD","LU0327786744.USD","LU0326950275.SGD","LU0348767384.USD","LU1719994722.HKD","LU0463099449.HKD","BK1590","LU1813983027.USD","603993","LU1969619763.USD","01929","LU1785774172.SGD","LU0072462343.USD","LU0862451753.SGD","LU0862451837.USD","IE00BWDBJ730.SGD","LU0051755006.USD","LU0417516738.SGD","SG9999004220.SGD","LU0469268626.HKD","LU0588546209.SGD","BK1575","BK1147","LU1282651121.HKD","LU0348825331.USD","LU1282651048.USD","LU1048588211.SGD","BK1564","CSUAY","81024","LU0540923850.HKD","LU0561508036.HKD","MCHmain","LU1961090484.USD","601088","600958","LU1328277881.USD","LU0359201885.HKD","TCOM","000333","09988","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633166139","title":"智通港股早知道 | 碳酸锂现货价格大幅上行 百济神州(06160)一季度净利润同比增长178.02倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2633166139","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633166139?lang=zh_cn&edition=full","pubTime":"2026-05-07 07:09","pubTimestamp":1778108970,"startTime":"0","endTime":"0","summary":"前十款智能手机合计贡献了全球 25% 的出货量,创下历年第一季度最高集中度。百济神州:一季度净利润同比增长178.02倍至2.27亿美元智通财经APP讯,百济神州公布2026年第一季度业绩,全球总收入达约15.13亿美元,同比增长35%。经调整经营利润约4.14亿美元,同比增长197%;经调整净利润约3.75亿美元,同比增长175%;净利润约2.27亿美元,同比增长178.02倍;自由现金流约1.61亿美元,同比增长14.03倍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","06160","ONC","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633139629","title":"核心产品放量!百济神州一季度营收达105亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633139629","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633139629?lang=zh_cn&edition=full","pubTime":"2026-05-06 21:26","pubTimestamp":1778073960,"startTime":"0","endTime":"0","summary":"5月6日,百济神州(纳斯达克代码:ONC;香港联交所代码:06160;上交所代码:688235.SH)发布2026年第一季度业绩报告。报告期内,公司营业总收入为105.44亿元,同比增长31.0%。产品收入占总营收98%,达103.21亿元,同比增长29.3%,主要得益于百悦泽?(泽布替尼),以及安进公司授权产品和百泽安?(替雷利珠单抗)的销售增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605063728968110.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605063728968110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180313","title":"百济神州(688235.SH):2026年第一季度归母净利润16.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180313","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633180313?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:37","pubTimestamp":1778067472,"startTime":"0","endTime":"0","summary":"百济神州(688235.SH)发布公告,2026年第一季度公司产品收入为103.21亿元,较上年同比上升29.3%;2026年第一季度公司营业总收入为105.44亿元,较上年同比上升31.0%;2026年第一季度归属于母公司所有者的净利润为16.08亿元。报告期末,公司总资产为590.69亿元,较期初增加3.1%;归属于母公司的所有者权益为330.31亿元,较期初增加7.8%。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/4.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"b1300d74fa2f8add3d36093521acc10f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688235","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196821259","title":"百济神州更新4月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1196821259","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196821259?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:26","pubTimestamp":1778066776,"startTime":"0","endTime":"0","summary":"百济神州于2026年5月6日公布了截至2026年4月30日的证券变动月报表。公告显示,截至本报告期末,公司注册股本为2,311,463,847股,面值为每股0.0001美元,法定/注册股本金额维持在USD 231,146.38,较上月底无变化。公司确认报告期内未发生新增发行、购回或注销股份等情况,整体股本保持稳定。公告显示,公司已确认符合香港联交所对公众持股量的相关要求,所有股份发行、期权、激励计划与库存股份处理均符合香港联交所《上市规则》及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175917767","title":"百济神州2026年第一季度营收15.13亿美元,经调整净利润3.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175917767","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175917767?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:47","pubTimestamp":1778064460,"startTime":"0","endTime":"0","summary":"2026年第一季度,百济神州实现营收15.13亿美元,同比增长35%。经调整净利润3.75亿美元,较上年同期的1.36亿美元增长175%。本季度公司毛利率从上年同期的85%提升至89%。销售及管理费用占产品收入比例从上年同期的41%下降至37%,经调整研发投入为4.66亿美元,同比增长11%。与此同时,自由现金流为1.61亿美元,较上年同期的-0.12亿美元大幅增长1403%。公司将2026财年营收指引上调至63亿至65亿美元。此外,经调整经营利润指引预计上调至14.5亿至15.5亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州2026年第一季度营收15.13亿美元,经调整净利润3.75亿美元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117917036","title":"百济神州Q1净利润16.08亿元,同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1117917036","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117917036?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:34","pubTimestamp":1778063668,"startTime":"0","endTime":"0","summary":"5月6日,$百济神州(ONC)$盘前涨近5%!该公司一季度营收为105.44亿元,同比增长31%;净利润为16.08亿元,上年同期亏损9450.3万元,同比扭亏为盈。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca0e3dea87604e6a95a3bf5695c5bcab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百济神州Q1净利润16.08亿元,同比扭亏为盈","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1303224171.USD","LU1719994722.HKD","LU2328871848.SGD","688235","LU1251922891.USD","LU1969619763.USD","BK0239","BK4588","LU0588546209.SGD","BK1588","BK4526","06160","BK1161","LU0307460666.USD","BK4585","ONC","BK1583","BK1500","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633189767","title":"百济神州最新公告:预计2026年营业收入436亿元-452亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633189767","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633189767?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:29","pubTimestamp":1778063396,"startTime":"0","endTime":"0","summary":"百济神州(688235.SH)公告称,公司调整2026年度经营业绩预测,预计营业收入将介于436亿元至452亿元之间,主要得益于百悦泽在美国市场的领先地位以及其在欧洲和全球其他重要市场的持续扩张。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600032287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632618011","title":"百济神州首次全年盈利背后:累计亏损超600亿元,大单品依赖与地缘政治隐忧|财报异动透视镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2632618011","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632618011?lang=zh_cn&edition=full","pubTime":"2026-05-01 16:32","pubTimestamp":1777624341,"startTime":"0","endTime":"0","summary":"这家中国抗癌药明星企业交出了史上首份盈利年报,但高达612亿元的累计未弥补亏损、对单一产品的深度依赖,以及愈演愈烈的中美药品定价博弈,令其“全球肿瘤创新公司”的故事蒙上阴影。对百济神州而言,2025年本应是举杯相庆的一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605013727283548.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605013727283548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142296902","title":"财报前瞻|百济神州盈利质量与BD进展成看点,盘后发布业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1142296902","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142296902?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:10","pubTimestamp":1777425014,"startTime":"0","endTime":"0","summary":"百济神州将于2026年05月06日盘后披露2026年第一季度财务业绩,市场关注利润质量、费用节奏与管线推进节奏。目前未检索到关于本季度营收、毛利率、净利润或净利率、调整后每股收益的明确一致预测以及公司在上季度财报中对本季度的定量指引,预计市场将围绕费用节奏与商业化进展作交易前置定价,待公司正式披露为准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻|百济神州盈利质量与BD进展成看点,盘后发布业绩","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2630323200","title":"盈利不足两月,百济神州豪掷20亿美元押注三抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2630323200","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630323200?lang=zh_cn&edition=full","pubTime":"2026-04-28 11:23","pubTimestamp":1777346580,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛从“年年巨亏”到“首年盈利”,百济神州用了十五年。当这面象征盈利喜悦的旗帜刚刚升起,百济神州在此节点选择花费重金与一家biotech企业达成BD(授权交易)合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604283721914325.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283721914325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4526","688235","BK4588","LU1303224171.USD","LU1969619763.USD","06160","BK4139","ONC","LU1719994722.HKD","LU1770034418.SGD","LU2328871848.SGD","BK0239","BK4585","BK1500","BK1588","LU1251922891.USD","LU0307460666.USD","BK1583","LU0588546209.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630393872","title":"百济神州(06160)与华辉安健签订《合作协议》引进三特异性创新药全球独家开发权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2630393872","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630393872?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:03","pubTimestamp":1777287828,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州 发布公告,2026 年 4 月 24 日,公司全资子公司百济神州广州与华辉安健签订了一份《合作协议》。此外,华辉安健同意在相关里程碑达成后,向百济神州广州支付其被百济神州广州授予相关知识产权许可的对价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688235","BK0239","06160","LU1251922891.USD","159992","BK1588","BK4526","LU2328871848.SGD","LU1719994722.HKD","LU1969619763.USD","BK4585","ONC","LU0307460666.USD","LU0588546209.SGD","LU1303224171.USD","LU1770034418.SGD","BK1161","BK1574","BK1583","BK1500","BK4139","06978","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630380141","title":"每周股票复盘:百济神州(688235)将发布2026年一季报","url":"https://stock-news.laohu8.com/highlight/detail?id=2630380141","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630380141?lang=zh_cn&edition=full","pubTime":"2026-04-26 02:43","pubTimestamp":1777142589,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,百济神州报收于234.86元,较上周的246.5元下跌4.72%。本周,百济神州4月20日盘中最高价报250.18元。本周关注点公司公告汇总:百济神州将于2026年5月6日发布第一季度未经审核财务业绩。公司公告汇总港股公告:2026年第一季度财务业绩公布日期及审计委员会行动通告百济神州有限公司将于2026年5月6日发布截至2026年3月31日的第一季度未经审核财务业绩,并由董事会审计委员会审阅及批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1719994722.HKD","BK1161","06160","LU0307460666.USD","LU0588546209.SGD","LU1303224171.USD","LU1251922891.USD","BK1500","LU2328871848.SGD","BK1583","BK0239","LU1969619763.USD","LU1770034418.SGD","BK1588","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628093746","title":"百济神州:公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定","url":"https://stock-news.laohu8.com/highlight/detail?id=2628093746","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628093746?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:30","pubTimestamp":1776677400,"startTime":"0","endTime":"0","summary":"证券日报网讯4月20日,百济神州在互动平台回答投资者提问时表示,公司已在2026年4月15日披露的《百济神州2025年年度报告》中详细披露报告期内的公司营业收入、销售费用、管理费用的变动原因。公司严格执行《企业会计准则》和各项具体会计准则、企业会计准则应用指南、企业会计准则解释及其他相关规定,财务数据客观公允反映公司财务状况和生产经营成果,不存在跨期结转成本费用的情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604203710742828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","LU1303224171.USD","LU1719994722.HKD","LU2328871848.SGD","688235","LU1251922891.USD","LU1969619763.USD","BK0239","BK4588","LU0588546209.SGD","BK1588","BK4526","06160","BK1161","LU0307460666.USD","BK4585","ONC","BK1583","BK1500","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.0881},{"period":"1month","weight":0.0075},{"period":"3month","weight":-0.0794},{"period":"6month","weight":-0.0079},{"period":"1year","weight":0.3397},{"period":"ytd","weight":0.0535}],"compareEarnings":[{"period":"1week","weight":0.033},{"period":"1month","weight":0.0601},{"period":"3month","weight":0.0025},{"period":"6month","weight":0.0147},{"period":"1year","weight":0.1734},{"period":"ytd","weight":0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG(原名:BeiGene Ltd)是一家全球肿瘤学公司,致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤,致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4(IgG4)抗程序性细胞死亡蛋白1(PD-1)单克隆抗体,具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ(Fcy)受体的结合,帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.034277},{"month":5,"riseRate":0.375,"avgChangeRate":-0.035104},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007027},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}